Evidence map›Paper›PMID 36643463›Full record

ArticleACS omega2023

Novel and Integrated Process for the Valorization of Kraft Lignin to Produce Lignin-Containing Vitrimers.

Ajinkya More, Thomas Elder, Nicolò Pajer, Dimitris S Argyropoulos, Zhihua Jiang

Abstract read
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ajinkya MoreAlabama Center for Paper and Bioresource Engineering (AC-PABE), Department of Chemical Engineering, Auburn University, Auburn, Alabama36849, United States.ORCID https://orcid.org/0000-0002-7312-6216
Thomas ElderUnited States Department of Agriculture, U.S. Forest Service, Southern Research Station, Auburn, Alabama36849, United States.ORCID https://orcid.org/0000-0003-3909-2152
Nicolò PajerDepartment of Molecular Sciences and Nanosystems, Ca' Foscari University of Venice, Via Torino 155, Venezia, Mestre30172, Italy.
Dimitris S ArgyropoulosDepartment of Forest Biomaterials, NC State University, Campus Box 8005, Raleigh, North Carolina27695-8005, United States.
Zhihua JiangAlabama Center for Paper and Bioresource Engineering (AC-PABE), Department of Chemical Engineering, Auburn University, Auburn, Alabama36849, United States.ORCID https://orcid.org/0000-0001-5020-7745

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The valorization of lignin into value-added products by oxidative conversion is a widely studied strategy. However, in many cases, this approach has limited scope for integration into industrial processes. The objective of our work is to maximize overall lignin utilization to produce diverse value-added products with a focus on integration in the existing industrial pulp and paper processes. The utilization of the sequential oxidation strategy using oxygen and ozone resulted in kraft lignin with a marked improvement in carboxyl content and also allowed the formation of vanillin and vanillic acid in the oxygen stage. The sequentially oxidized lignin (OxL-COOH) was then cured with poly(ethylene glycol) diglycidyl ether (PEG-epoxy) to form high-lignin-content (>48 wt %) vitrimers with high thermal stability, fast relaxation, swelling, and self-healing due to the presence of bond-exchangeable cross-linked networks. Overall, this study provides a novel approach for the multidimensional valorization of lignin and demonstrates an integrated approach for kraft lignin valorization in the pulp and paper industry.

Identifiers

PMID36643463
PMCPMC9835646

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.